Cargando…
Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies
A strategy in the discovery of anti-tuberculosis (anti-TB) drug involves targeting the enzymes involved in the biosynthesis of Mycobacterium tuberculosis’ (Mtb) cell wall. One of these enzymes is Galactofuranosyltransferase 2 (GlfT2) that catalyzes the elongation of the galactan chain of Mtb cell wa...
Autores principales: | Ortiz, Christopher Llynard D., Completo, Gladys C., Nacario, Ruel C., Nellas, Ricky B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863818/ https://www.ncbi.nlm.nih.gov/pubmed/31745103 http://dx.doi.org/10.1038/s41598-019-52764-8 |
Ejemplares similares
-
Synthesis and Evaluation of Bicyclo[3.1.0]hexane-Based UDP-Galf Analogues as Inhibitors of the Mycobacterial Galactofuranosyltransferase GlfT2
por: Lowary, Todd L., et al.
Publicado: (2016) -
Synthesis, docking study and biological evaluation of ᴅ-fructofuranosyl and ᴅ-tagatofuranosyl sulfones as potential inhibitors of the mycobacterial galactan synthesis targeting the galactofuranosyltransferase GlfT2
por: Baráth, Marek, et al.
Publicado: (2020) -
Catalytic Mechanism of Processive GlfT2: Transition
Path Sampling Investigation of Substrate Translocation
por: Janoš, Pavel, et al.
Publicado: (2020) -
Integrating Computational
Methods in Network Pharmacology
and In Silico Screening to Uncover Multi-targeting
Phytochemicals against Aberrant Protein Glycosylation in Lung Cancer
por: Grijaldo, Sheryl Joyce B., et al.
Publicado: (2023) -
Reinstating apoptosis using putative Bcl-xL natural product inhibitors: Molecular docking and ADMETox profiling investigations
por: Boyenle, Ibrahim Damilare, et al.
Publicado: (2022)